Home LiteratureArticle Details
PMID: 8668202 Published · ppublish English Journal Article

Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.

Molecular and cellular biology ·Vol. 16 ·No. 7 ·1996-07-00 ·Pages 3844-52

Parry D, Peters G

Abstract

Altered expression or function of the p16CDKN2 tumor suppressor gene on chromosome 9p21 occurs in a wide range of human tumors, and mutations in the gene have been shown to segregate with familial predisposition to malignant melanoma. We have used a variety of assays to examine the functional properties of tumor-associated alleles, including eight premature termination mutants, eight missense mutants, and three isoforms of p16 initiated at different amino-terminal methionine codons. The amino- and carboxy-terminal domains of the protein, outside the ankyrin-like repeats, appeared to be dispensable, but the majority of the premature termination mutations led to loss of function. Of the missense mutations tested, four displayed clear loss of function whereas two behaved like the wild type under all conditions tested. The remaining two mutations, a G-to-W mutation at position 101 (Gl01W) and V126D, both of which are associated with familial melanoma, were found to be temperature sensitive for binding to Cdk4 and Cdk6 in vitro, for inhibiting cyclin D1-Cdk4 in a reconstituted pRb-kinase assay, and for increasing the proportion of G1-phase cells following transfection. These findings clarify previous disparities and argue strongly that p16CDKN2 is a bona fide tumor suppressor associated with familial melanoma.

MeSH Terms
Bone Neoplasms Carrier Proteins/biosynthesis,genetics,metabolism Cell Line Chromosome Mapping Chromosomes, Human, Pair 9 Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinases/antagonists & inhibitors,biosynthesis Enzyme Inhibitors Genes, Tumor Suppressor Genetic Variation Humans Melanoma/genetics Mutagenesis, Site-Directed Mutation Osteosarcoma Point Mutation Protein Biosynthesis Proto-Oncogene Proteins Recombinant Proteins/biosynthesis,metabolism Sequence Deletion Temperature Transfection Tumor Cells, Cultured
Chemicals
Carrier Proteins Cyclin-Dependent Kinase Inhibitor p16 Enzyme Inhibitors Proto-Oncogene Proteins Recombinant Proteins CDK4 protein, human Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Parry D
Imperial Cancer Research Fund Laboratories, London, United Kingdom.
Peters G
References (62)
62 references, click to expand
  1. Mutations and altered expression of p16INK4 in human cancer.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11045-9 PMID: 7972006
  2. Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes.
    Cancer Res. 1994 Oct 1;54(19):5045-9 PMID: 7923114
  3. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
    Nat Genet. 1994 Sep;8(1):23-6 PMID: 7987388
  4. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.
    Nat Genet. 1994 Sep;8(1):27-32 PMID: 7726912
  5. Deletion of p16 and p15 genes in brain tumors.
    Cancer Res. 1994 Dec 15;54(24):6353-8 PMID: 7987828
  6. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.
    Blood. 1994 Dec 15;84(12):4038-44 PMID: 7994022
  7. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.
    Cancer Res. 1994 Oct 1;54(19):5050-3 PMID: 7923115
  8. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.
    Cancer Res. 1994 Oct 15;54(20):5269-72 PMID: 7923152
  9. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
    Oncogene. 1995 Mar 16;10(6):1061-7 PMID: 7700630
  10. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Genes Dev. 1995 May 15;9(10):1149-63 PMID: 7758941
  11. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Nature. 1995 Jun 8;375(6531):503-6 PMID: 7777060
  12. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition.
    Nature. 1995 Jun 8;375(6531):506-10 PMID: 7777061
  13. Mutational effects on the p16INK4a tumor suppressor protein.
    Cancer Res. 1995 Jun 15;55(12):2503-6 PMID: 7780957
  14. Complex structure and regulation of the P16 (MTS1) locus.
    Cancer Res. 1995 Jul 15;55(14):2988-94 PMID: 7606716
  15. A novel p16INK4A transcript.
    Cancer Res. 1995 Jul 15;55(14):2995-7 PMID: 7541708
  16. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.
    Oncogene. 1995 Jul 6;11(1):21-9 PMID: 7624129
  17. Mutations associated with familial melanoma impair p16INK4 function.
    Nat Genet. 1995 May;10(1):114-6 PMID: 7647780
  18. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts.
    Mol Cell Biol. 1995 Sep;15(9):4745-53 PMID: 7651392
  19. Cloning and characterization of murine p16INK4a and p15INK4b genes.
    Oncogene. 1995 Aug 17;11(4):635-45 PMID: 7651726
  20. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.
    Oncogene. 1995 Aug 17;11(4):663-8 PMID: 7651729
  21. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
    Science. 1995 Sep 1;269(5228):1281-4 PMID: 7652577
  22. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
    Nat Genet. 1995 Jul;10(3):351-3 PMID: 7670475
  23. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
    Oncogene. 1995 Sep 7;11(5):987-91 PMID: 7675459
  24. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Cancer Res. 1995 Oct 15;55(20):4525-30 PMID: 7553621
  25. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Cancer Res. 1995 Oct 15;55(20):4531-5 PMID: 7553622
  26. p16 proteins from melanoma-prone families are deficient in binding to Cdk4.
    Oncogene. 1995 Sep 21;11(6):1173-8 PMID: 7566978
  27. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine.
    Oncogene. 1995 Sep 21;11(6):1211-6 PMID: 7566983
  28. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.
    Oncogene. 1995 Oct 19;11(8):1581-8 PMID: 7478582
  29. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
    Nat Med. 1995 Jul;1(7):686-92 PMID: 7585152
  30. Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16.
    Oncogene. 1995 Nov 16;11(10):2013-9 PMID: 7478520
  31. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.
    Cell. 1995 Dec 15;83(6):993-1000 PMID: 8521522
  32. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.
    Hum Mol Genet. 1995 Oct;4(10):1845-52 PMID: 8595405
  33. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.
    Hum Mol Genet. 1995 Oct;4(10):1883-7 PMID: 8595411
  34. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
    Nat Genet. 1996 Jan;12(1):97-9 PMID: 8528263
  35. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence.
    Mol Cell Biol. 1996 Mar;16(3):859-67 PMID: 8622687
  36. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
    Adv Cancer Res. 1996;68:67-108 PMID: 8712071
  37. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A.
    Curr Biol. 1996 Jan 1;6(1):84-91 PMID: 8805225
  38. MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma.
    Carcinogenesis. 1994 Dec;15(12):2683-6 PMID: 8001221
  39. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Genes Dev. 1994 Dec 15;8(24):2939-52 PMID: 8001816
  40. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p.
    Hum Mol Genet. 1994 Oct;3(10):1841-5 PMID: 7849711
  41. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.
    EMBO J. 1995 Feb 1;14(3):503-11 PMID: 7859739
  42. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Am J Pathol. 1995 Mar;146(3):613-9 PMID: 7887443
  43. Tumor suppression. Lessons in p16 from phylum Falconium.
    Curr Biol. 1995 Jan 1;5(1):28-31 PMID: 7697342
  44. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
    J Clin Invest. 1991 Mar;87(3):1046-53 PMID: 1900307
  45. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.
    Science. 1992 Nov 13;258(5085):1148-52 PMID: 1439824
  46. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
    Genes Dev. 1993 Mar;7(3):331-42 PMID: 8449399
  47. Confirmation of chromosome 9p linkage in familial melanoma.
    Am J Hum Genet. 1993 Oct;53(4):936-42 PMID: 8213823
  48. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
    Cancer Res. 1993 Nov 15;53(22):5535-41 PMID: 8221695
  49. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Nature. 1993 Dec 16;366(6456):704-7 PMID: 8259215
  50. Distinct roles for cyclin-dependent kinases in cell cycle control.
    Science. 1993 Dec 24;262(5142):2050-4 PMID: 8266103
  51. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
    Am J Hum Genet. 1994 Mar;54(3):489-96 PMID: 8116618
  52. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.
    Nature. 1994 Apr 21;368(6473):753-6 PMID: 8152487
  53. A cell cycle regulator potentially involved in genesis of many tumor types.
    Science. 1994 Apr 15;264(5157):436-40 PMID: 8153634
  54. A challenge to p16 gene as a major tumor suppressor.
    Science. 1994 Jun 24;264(5167):1846 PMID: 8009205
  55. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.
    Cancer Res. 1994 Jul 1;54(13):3396-7 PMID: 8012957
  56. Chromosome 11q13 abnormalities in human breast cancer.
    Cancer Surv. 1993;18:77-94 PMID: 8013002
  57. Rates of p16 (MTS1) mutations in primary tumors with 9p loss.
    Science. 1994 Jul 15;265(5170):415-7 PMID: 8023167
  58. Tumor-suppressor genes. Open questions on p16.
    Nature. 1994 Jul 21;370(6486):180 PMID: 8028659
  59. p16 gene in uncultured tumours.
    Nature. 1994 Jul 21;370(6486):183-4 PMID: 8028660
  60. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas.
    Biochem Biophys Res Commun. 1994 Aug 15;202(3):1426-30 PMID: 8060323
  61. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
    Nature. 1994 Sep 15;371(6494):257-61 PMID: 8078588
  62. Germline p16 mutations in familial melanoma.
    Nat Genet. 1994 Sep;8(1):15-21 PMID: 7987387
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1996-07-00
Pages
3844-52
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC231381
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]